|
|
Article: Venture Funds Provide $29M For Scynexis Discovery Work.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
Investors found the "chemistry" just right in Scynexis Inc. and came together in a synthesis of U.S. and European venture funds that contributed $29 million to the company's efforts in synthesis chemistry.
Scynexis (and Scynexis Europe Ltd., of Cambridge, UK) works on drug discovery through chemists' research coupled with technologies called Medchem-Factory and the Hit Explorer Operating System.
"We aren't nebulous or way over the horizon," said Terry Marquardt, director of business development for Research Triangle Park, N.C.-based Scynexis. "We're generating income now, and we have a plan for fee for service and we can ...